Marrone Bio Innov (MBII) Misses Q1 EPS by 14c

Marrone Bio Innov (NASDAQ: MBII) reported Q1 EPS of ($0.52), $0.14 worse than the analyst estimate of ($0.38). Revenue for the quarter came in at $2.8 million versus the consensus estimate of $4.63 million.

For earnings history and earnings-related data on Marrone Bio Innov (MBII) click here.

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• Baidu (BIDU) PT Lowered to $150 at Benchmark on Near-Term Margin Concerns
• TJX Cos. (TJX) Tops Q2 EPS by 3c, Beats on Revenue; Offers FY27 EPS Guidance